GEN Exclusives

More »

GEN News Highlights

More »
Oct 19, 2006

Inovio Biomedical Receives Grant for its Gene Delivery System for Vaccinations Against Infectious Diseases

  • Inovio Biomedical will receive an appropriation of $1.1 million from the DoD to develop applications of its electroporation-based gene delivery technology for vaccination against infectious diseases, including potential bioterrorism agents.

    Inovio’s gene delivery system for gene-based immunization uses intramuscular electroporation to enhance the cellular delivery and expression of the DNA agents to produce the desired antigens. Compared to conventional vaccines, DNA vaccines delivered using electroporation may accelerate the onset and enhance the level of immunity generated, Inovio explains. Pertinent genes can be quickly identified and isolated from potential infectious organisms, sequenced, and synthesized for vaccination of the general population or military to induce a protective immune response, the company adds.

    The U.S. Congress appropriated the funding in the Defense Appropriations Bill for 2007. It is a continuation of prior funding from the U.S. Army, focussing on the development of a more effective gene delivery system for gene-based vaccines.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?